| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/05/2000 | EP1015610A2 Medicament for treating a manifested lyme disease |
| 07/05/2000 | EP1015607A1 Dna encoding a ras carboxyl-terminal processing protein |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015602A1 Glutrna gln amidotransferase - a novel essential translational component |
| 07/05/2000 | EP1015593A1 Hepatitis b virus polypeptides |
| 07/05/2000 | EP1015588A1 Cell growth regulator |
| 07/05/2000 | EP1015587A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| 07/05/2000 | EP1015586A2 Tie receptor tyrosine kinase ligand homologues |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015584A1 Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis |
| 07/05/2000 | EP1015583A2 Protein containing an srcr domain |
| 07/05/2000 | EP1015578A1 Therapeutic molecules |
| 07/05/2000 | EP1015570A1 Fibrin microbeads and uses thereof |
| 07/05/2000 | EP1015568A1 METHOD FOR THE PRODUCTION OF rDSPA Alpha1 |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015559A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
| 07/05/2000 | EP1015496A2 Immuntoxins and methods of inducing immune tolerance |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015492A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/05/2000 | EP1015491A1 Method for purification of antithrombin iii |
| 07/05/2000 | EP1015490A1 No-modified hemoglobins and uses therefor |
| 07/05/2000 | EP1015488A1 Interleukin-17 receptor-like protein |
| 07/05/2000 | EP1015487A2 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof |
| 07/05/2000 | EP1015486A2 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
| 07/05/2000 | EP1015485A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections |
| 07/05/2000 | EP1015484A1 Peptides derived from complement peptide c3a sequence and antiallergic compositions comprising them |
| 07/05/2000 | EP1015483A1 Malaria polypeptides |
| 07/05/2000 | EP1015482A1 Isolated candida albicans oligopeptide transporter gene |
| 07/05/2000 | EP1015481A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 07/05/2000 | EP1015477A1 32 human secreted proteins |
| 07/05/2000 | EP1015474A1 Don-1 gene and polypeptides and uses therefor |
| 07/05/2000 | EP1015473A1 CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R) |
| 07/05/2000 | EP1015471A1 Hypoxia-regulated genes |
| 07/05/2000 | EP1015468A1 Follistatin-3 |
| 07/05/2000 | EP1015439A1 Prenyl transferase inhibitors |
| 07/05/2000 | EP1015036A1 Improvements in or relating to expression of immunogenic substances |
| 07/05/2000 | EP1015034A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 07/05/2000 | EP1015029A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent |
| 07/05/2000 | EP1015027A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 07/05/2000 | EP1015026A2 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 07/05/2000 | EP1015022A1 New improved formulation for treatment of thromboembolism |
| 07/05/2000 | EP1015021A2 Agents for combating bacterial meningitis |
| 07/05/2000 | EP1015020A1 Pharmaceutical substance containing various vitamin k-dependent factors |
| 07/05/2000 | EP1015019A1 Compositions and methods of therapy for igf-i-responsive conditions |
| 07/05/2000 | EP1015018A1 Veterinary medicine containing native or modified equine chorionic gonadotropin |
| 07/05/2000 | EP1015017A1 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 07/05/2000 | EP1015016A1 Methods and compositions for preventing autoimmune disease |
| 07/05/2000 | EP1015015A1 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 07/05/2000 | EP1015014A1 Methods and compositions for inhibiting angiogenesis |
| 07/05/2000 | EP1015013A1 TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES |
| 07/05/2000 | EP1015012A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 07/05/2000 | EP1015011A1 Peptide nucleic acids having antibacterial activity |
| 07/05/2000 | EP1015010A1 Prevention of pregnancy miscarriages |
| 07/05/2000 | EP1015009A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 07/05/2000 | EP1015008A1 Compounds and compositions for delivering active agents |
| 07/05/2000 | EP1015007A1 Analogs of peptide yy and uses thereof |
| 07/05/2000 | EP1015003A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 07/05/2000 | EP1014989A1 Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 07/05/2000 | EP1014956A1 Methods of using integrin modulators |
| 07/05/2000 | EP1014950A1 Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof |
| 07/05/2000 | EP1014947A1 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein |
| 07/05/2000 | EP1014885A1 Method of treating involuntary muscle dysfunction with relaxin hormone |
| 07/05/2000 | EP0871664A4 Novel chemokine for mobilizing stem cells |
| 07/05/2000 | EP0853487B1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/05/2000 | EP0752877B1 Stabilized composition for oral administration of peptides |
| 07/05/2000 | EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications |
| 07/05/2000 | EP0724596B1 Method and means for producing plasmaproteinase inhibitor-binding proteins |
| 07/05/2000 | EP0702691B1 New thiodepsipeptide isolated from a marine actinomycete |
| 07/05/2000 | EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 07/05/2000 | EP0619839B1 Novel polypeptides for promoting cell attachment |
| 07/05/2000 | EP0577752B1 Human pf4a receptors and their use |
| 07/05/2000 | EP0528891B1 Method for increasing blood-brain barrier permeability |
| 07/05/2000 | CN1259165A Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
| 07/05/2000 | CN1259142A Zinc free insulin crystals for use in pulmonary compositions |
| 07/05/2000 | CN1259141A PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 07/05/2000 | CN1259140A Treatment of insulin resistance with growth hormone secretagogues |
| 07/05/2000 | CN1259139A Prevention and treatment of hepatocellular cancer |
| 07/05/2000 | CN1259045A Method for oral delivery of proteins |
| 07/05/2000 | CN1259043A Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein |
| 07/05/2000 | CN1259040A Compositions and methods for inhibiting photoaging of skin |
| 07/05/2000 | CN1259039A Keratin fibre oxidation dyeing composition and dyeing method using same |
| 07/05/2000 | CN1258748A Preparation and application of rhBTR gene and gene probe |
| 07/05/2000 | CN1258512A Lycium chinense glycopeptide and its production process |
| 07/05/2000 | CA2257804A1 Treatment of hiv-associated dysmorphia/dysmetabolic syndrome |
| 07/04/2000 | US6084156 Plants producing lytic peptides |
| 07/04/2000 | US6084152 Method for producing transgenic cucumber that produces high levels of superoxide dismutase |
| 07/04/2000 | US6084090 Human papilloma virus anti-sense oligonucleotides |
| 07/04/2000 | US6084088 Polynucleotides encoding novel tumor antigens |
| 07/04/2000 | US6084087 Amino acid sequences; for diagnosis and treatment of rheumatoid arthritis; antiarthritic agents |
| 07/04/2000 | US6084085 Inducing resistance to tumor growth with soluble IGF-1 receptor |
| 07/04/2000 | US6084084 Nucleotide and amino acid sequences; for anticonvulsants, neuroprotectants, analgesics and cognition enhancers; for diagnosis and therapy of related nervous system disorders |
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6084074 Stabilized aqueous liquid preparations of blood coagulation factor XIII |
| 07/04/2000 | US6084072 Purified lectin and methods of use |
| 07/04/2000 | US6084070 Amino acid sequence of glutathione-dependent hydrogen donor for ribonucleotide reductase; for diagnosis, prevention, and treatment of immunological/autoimmune and neoplastic disorders; anticancer/antitumor/antiarthritic agents |
| 07/04/2000 | US6084069 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 07/04/2000 | US6084067 CTLA4/CD28 ligands and uses therefor |
| 07/04/2000 | US6084066 Polypetides that include conformation-constraining groups which flank a protein-protein interaction site |
| 07/04/2000 | US6084063 Polypeptide of amino acids 1-66 of human tyrosine kinase, lyn a, in pharmaceutically acceptable carrier; capable of binding cytoplasmic domain of high affinity ligand for immunoglobulin e, fc epsilon ri, to suppress signaling and histamine release |